# Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd., Changzhou, China – FDA Inspections

Source: https://www.keypedia.com/companies/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/7ccd91ae-2b6a-43f7-acc5-6c182cec0d11

> Inspection records and compliance data for Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. in Changzhou. 5 FDA inspections on record, 2 Form 483s, last inspected September 12, 2025.

---

## Details

- Name: Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
- FEI Number: 3001599766
- Address Line 1: No. 302 Huzhuangtou, Sanhuangmiao, Zhenglu, Tianning
- City: Changzhou
- Country Name: China
- Address: No. 302 Huzhuangtou, Sanhuangmiao, Zhenglu, Tianning, Changzhou, China
- Country: China

## Related Documents

- [483 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - Unknown Date](https://www.keypedia.com/records/483/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/88731eb4-5ab6-4b2a-b83c-bc408946c100) — source: FDA, date: Invalid Date
- [FDA Inspection 1291762 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2025-09-12](https://www.keypedia.com/records/fda_inspections/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/c2c213cd-18f2-411d-ae2c-0cdf6a37b1b1) — source: FDA, date: September 12, 2025
- FDA Inspection 1291762 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2025-09-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 12, 2025
- [FDA Inspection 1064555 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2018-07-26](https://www.keypedia.com/records/fda_inspections/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/76f31d23-dc60-4c76-a4bd-6bd188cf3544) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2018
- [FDA Inspection 886759 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2014-06-12](https://www.keypedia.com/records/fda_inspections/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/4c1da626-2c55-4542-a1dd-225782a2a583) — classification: No Action Indicated (NAI), source: FDA, date: June 12, 2014
- [FDA Inspection 728837 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2011-04-28](https://www.keypedia.com/records/fda_inspections/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/1a0acf84-58b5-412d-b164-2149f201c646) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2011
- FDA Inspection 615933 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2009-09-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 17, 2009

## Related Companies

- [Merck Serono SA (Vevey)](https://www.keypedia.com/companies/merck-serono-sa-vevey/e86df39a-6cb6-4ab2-a811-47c8369ba270)
- [SCI Pharmtech Inc.](https://www.keypedia.com/companies/sci-pharmtech-inc/38edf740-19b5-4fbf-bd65-e8cd87a7b1db)
- [Concord Biotech Limited](https://www.keypedia.com/companies/concord-biotech-limited/84ea17c0-5c3b-40cc-9098-13c3031fe2dc)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/fc196e7f-0f5e-4ef1-afa6-3023ca6df1f3)
- [Kyongbo Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/kyongbo-pharmaceutical-co-ltd/6b8fd90f-4fa3-4c7b-9ed6-a8a8f4b511da)
- [Olon SPA](https://www.keypedia.com/companies/olon-spa/7df58e77-f9cb-4929-8d1b-0f9a728b86cf)
- [Signa S.A. de C.V.](https://www.keypedia.com/companies/signa-sa-de-cv/378a704e-5acb-49b8-9cd6-32503b29b3fc)
- [Janssen Sciences Ireland UC](https://www.keypedia.com/companies/janssen-sciences-ireland-uc/dcb988ee-73e6-4408-afcd-1a6730ea40b1)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/da6311ed-b3e1-4d8b-b794-8804a9eda435)
- [Sun Pharmaceutical Industries Ltd.](https://www.keypedia.com/companies/sun-pharmaceutical-industries-ltd/a3b25a73-6014-41fa-802f-abd1fe33382c)

## Related Officers

- [Investigator](https://www.keypedia.com/people/truong-x-nguyen/8f3aed17-0507-4272-a3b8-9188d761faed)
